We used retrospective prognostic data from the public repository Tumor Immune Estimation Resource (TIMER 2.0) to analyze immune cell infiltration and gene expression and to understand the importance of CD103+ CD8+ TRM cells in the prognosis of EC. The gene discussed is CD8A; the disease is neoplasm.